Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 37.30M | £ 43.90M | £ 57.00M | £ 40.70M | £ 32.60M |
Total Assets | £ 3.53B | £ 3.66B | £ 3.05B | £ 2.63B | £ 2.48B |
Total Debt | £ 1.19B | £ 1.03B | £ 1.04B | £ 842.70M | £ 841.70M |
Net Debt | £ 1.15B | £ 982.10M | £ 984.20M | £ 802.00M | £ 809.10M |
Total Liabilities | £ 1.25B | £ 1.09B | £ 1.09B | £ 888.70M | £ 879.90M |
Stockholders Equity | £ 2.27B | £ 2.56B | £ 1.95B | £ 1.73B | £ 1.60B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |